We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
LAURUSLABS.NSE

Price
1010.00
Stock movement up
+8.70 (0.87%)
Company name
Laurus Labs Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
545.26B
Ent value
589.44B
Price/Sales
8.58
Price/Book
11.05
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
79.72
Forward P/E
93.85
PEG
-
EPS growth
6.77%
1 year return
76.54%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-12-17

DIVIDENDS

LAURUSLABS.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E79.72
Price to OCF32.17
Price to FCF96.53
Price to EBITDA31.49
EV to EBITDA34.04

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales8.58
Price to Book11.05
EV to Sales9.27

FINANCIALS

Per share

Per share data
Current share count539.86M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)10.76

Margins

Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash633.80M
Net receivables18.61B
Total current assets41.91B
Goodwill2.46B
Intangible assets177.30M
Property, plant and equipment0.00
Total assets94.15B
Accounts payable10.14B
Short/Current long term debt22.12B
Total current liabilities31.75B
Total liabilities44.82B
Shareholder's equity49.34B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Stock price data
Open1005.90
Daily high1018.80
Daily low1001.60
Daily Volume1.28M
All-time high1031.35
1y analyst estimate821.93
Beta0.39
EPS (TTM)-
Dividend per share0.00
Ex-div date31 Oct 2025
Next earnings date23 Jan 2026

Downside potential

Downside potential data
LAURUSLABS.NSES&P500
Current price drop from All-time high-2.07%-2.58%
Highest price drop-36.88%-19.00%
Date of highest drop24 Oct 20248 Apr 2025
Avg drop from high-12.27%-2.63%
Avg time to new high10 days6 days
Max time to new high180 days89 days
COMPANY DETAILS
LAURUSLABS.NSE (Laurus Labs Limited) company logo
Marketcap
545.26B
Marketcap category
Large-cap
Description
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
Employees
6167
Website
https://www.lauruslabs.com
Investor relations
-
SEC filings
LAURUSLABS.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesFeatured ArticlesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved